Parameters | Category | No. of cases | OS | PFS | LRRFS | DMFS | ||||
---|---|---|---|---|---|---|---|---|---|---|
Events | P | Events | P | Events | P | Events | P | |||
STC2 | Positive | 65 | 12 | 0.049* | 22 | 0.007* | 10 | 0.250 | 14 | 0.028* |
Negative | 29 | 1 | 2 | 2 | 1 | |||||
Gender | Male | 68 | 11 | 0.190 | 20 | 0.162 | 10 | 0.336 | 13 | 0.190 |
Female | 26 | 2 | 4 | 2 | 2 | |||||
Age | ≤ 50 years | 50 | 5 | 0.288 | 11 | 0.371 | 8 | 0.365 | 5 | 0.083 |
>50 years | 44 | 8 | 13 | 4 | 10 | |||||
T classification | 1-2 | 29 | 2 | 0.151 | 6 | 0.441 | 5 | 0.411 | 3 | 0.269 |
3-4 | 65 | 11 | 18 | 7 | 12 | |||||
N classification | 0-1 | 50 | 4 | 0.070 | 11 | 0.270 | 6 | 0.709 | 6 | 0.200 |
2-3 | 44 | 9 | 13 | 6 | 9 | |||||
Clinical stage | I | 4 | 0 | 0.004* | 0 | 0.472 | 0 | 0.781 | 0 | 0.317 |
II | 10 | 0 | 2 | 2 | 0 | |||||
III | 50 | 4 | 13 | 6 | 9 | |||||
IV | 30 | 9 | 9 | 4 | 6 | |||||
Treatment | RT alone | 18 | 4 | 0.360 | 5 | 0.783 | 1 | 0.324 | 4 | 0.373 |
CRT | 76 | 9 | 19 | 11 | 11 | |||||
Radiotherapy | IMRT | 54 | 3 | 0.008* | 10 | 0.050* | 2 | 0.001* | 5 | 0.567 |
2D-RT | 40 | 10 | 14 | 10 | 14 | |||||
Residual | Yes | 32 | 4 | 0.875 | 4 | 0.048* | 2 | 0.194 | 3 | 0.211 |
No | 62 | 9 | 20 | 10 | 12 |